BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24415573)

  • 1. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
    Kraus V; Srivastava R; Kalluri SR; Seidel U; Schuelke M; Schimmel M; Rostasy K; Leiz S; Hosie S; Grummel V; Hemmer B
    Neurology; 2014 Feb; 82(6):470-3. PubMed ID: 24415573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel KIR4.1 as an immune target in multiple sclerosis.
    Srivastava R; Aslam M; Kalluri SR; Schirmer L; Buck D; Tackenberg B; Rothhammer V; Chan A; Gold R; Berthele A; Bennett JL; Korn T; Hemmer B
    N Engl J Med; 2012 Jul; 367(2):115-23. PubMed ID: 22784115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
    Nerrant E; Salsac C; Charif M; Ayrignac X; Carra-Dalliere C; Castelnovo G; Goulabchand R; Tisseyre J; Raoul C; Eliaou JF; Labauge P; Vincent T
    Mult Scler; 2014 Nov; 20(13):1699-703. PubMed ID: 24756568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
    Brill L; Goldberg L; Karni A; Petrou P; Abramsky O; Ovadia H; Ben-Hur T; Karussis D; Vaknin-Dembinsky A
    Mult Scler; 2015 Apr; 21(5):572-9. PubMed ID: 25392324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
    Schirmer L; Srivastava R; Kalluri SR; Böttinger S; Herwerth M; Carassiti D; Srivastava B; Gempt J; Schlegel J; Kuhlmann T; Korn T; Reynolds R; Hemmer B
    Ann Neurol; 2014 Jun; 75(6):810-28. PubMed ID: 24777949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
    Malyavantham K; Weinstock-Guttman B; Suresh L; Zivadinov R; Shanahan T; Badgett D; Ramanathan M
    PLoS One; 2015; 10(6):e0129503. PubMed ID: 26065913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
    Brickshawana A; Hinson SR; Romero MF; Lucchinetti CF; Guo Y; Buttmann M; McKeon A; Pittock SJ; Chang MH; Chen AP; Kryzer TJ; Fryer JP; Jenkins SM; Cabre P; Lennon VA
    Lancet Neurol; 2014 Aug; 13(8):795-806. PubMed ID: 25008548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics.
    Lui A; Chong J; Flanagan E; Abrams AW; Krysko KM; Arikan B; Francisco C; Rutatangwa A; Waubant E; Ziaei A
    Mult Scler Relat Disord; 2021 Nov; 56():103253. PubMed ID: 34517190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
    Kakalacheva K; Regenass S; Wiesmayr S; Azzi T; Berger C; Dale RC; Brilot F; Münz C; Rostasy K; Nadal D; Lünemann JD
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26907324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.
    Marnetto F; Valentino P; Caldano M; Bertolotto A
    J Immunol Methods; 2017 Jun; 445():53-58. PubMed ID: 28300540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low reliability of anti-KIR4.1
    Marino M; Frisullo G; Di Sante G; Samengo DM; Provenzano C; Mirabella M; Pani G; Ria F; Bartoccioni E
    Mult Scler; 2018 Jun; 24(7):910-918. PubMed ID: 28548026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
    Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
    Pröbstel AK; Dornmair K; Bittner R; Sperl P; Jenne D; Magalhaes S; Villalobos A; Breithaupt C; Weissert R; Jacob U; Krumbholz M; Kuempfel T; Blaschek A; Stark W; Gärtner J; Pohl D; Rostasy K; Weber F; Forne I; Khademi M; Olsson T; Brilot F; Tantsis E; Dale RC; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E; Derfuss T
    Neurology; 2011 Aug; 77(6):580-8. PubMed ID: 21795651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease mechanisms in MS: the potassium channel KIR4.1--a potential autoantigen in MS.
    Racke MK
    Nat Rev Neurol; 2012 Nov; 8(11):595-6. PubMed ID: 22986435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.
    Imamura M; Higuchi O; Maeda Y; Mukaino A; Ueda M; Matsuo H; Nakane S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies--conflicting results?
    Hemmer B
    Mult Scler; 2015 Apr; 21(5):537-9. PubMed ID: 25583849
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
    Jarius S; Metz I; König FB; Ruprecht K; Reindl M; Paul F; Brück W; Wildemann B
    Mult Scler; 2016 Oct; 22(12):1541-1549. PubMed ID: 26869529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).
    Brehm U; Piddlesden SJ; Gardinier MV; Linington C
    J Neuroimmunol; 1999 Jun; 97(1-2):9-15. PubMed ID: 10408984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.